Literature DB >> 9200519

Gas chromatographic-mass spectrometry and gas chromatographic-Fourier transform infrared spectroscopy assay for the simultaneous identification of fentanyl metabolites.

J Guitton1, M Désage, S Alamercery, L Dutruch, S Dautraix, J P Perdrix, J L Brazier.   

Abstract

Fentanyl, a synthetic opioid, undergoes important biotransformation to several metabolites. A gas chromatographic-mass spectrometric assay was applied for the simultaneous analysis of fentanyl and its major metabolites in biological samples. The identification of different metabolites was performed by gas chromatography-mass spectrometry (electronic impact and chemical ionisation modes) and gas chromatography-Fourier transform infrared spectroscopy. In the present study, rat and human microsomes incubation mixtures and human urines were analysed. In vitro formation of already known fentanyl metabolites was confirmed. The presence of metabolites not previously detected in human urine is described.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200519     DOI: 10.1016/s0378-4347(97)00050-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  3 in total

1.  Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Authors:  Nina Sophia Mahlke; Victoria Ziesenitz; Gerd Mikus; Gisela Skopp
Journal:  Int J Legal Med       Date:  2014-07-06       Impact factor: 2.686

Review 2.  Current and Future Perspectives on the Structural Identification of Small Molecules in Biological Systems.

Authors:  Daniel A Dias; Oliver A H Jones; David J Beale; Berin A Boughton; Devin Benheim; Konstantinos A Kouremenos; Jean-Luc Wolfender; David S Wishart
Journal:  Metabolites       Date:  2016-12-15

Review 3.  Postmortem Toxicology of New Synthetic Opioids.

Authors:  Marta Concheiro; Rachel Chesser; Justine Pardi; Gail Cooper
Journal:  Front Pharmacol       Date:  2018-10-26       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.